Dyne Therapeutics Announces Positive Initial Clinical Data from DELIVER Trial in Duchenne Patients
Dyne Therapeutics today announced positive initial clinical data from its DELIVER trial of DYNE-251 in patients with Duchenne who are amenable to exon 51 skipping. Dyne-251 is an exon skipping product that combines a PMO…Learn More